Clinical Trials: Depression

Birmingham : The University of Alabama at Birmingham, Office of Psychiatric Research

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Birmingham : The University of Alabama at Birmingham, Office of Psychiatric Research

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Birmingham : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Birmingham : Updated

A Study of Ketamine in Patients With Treatment-resistant Depression

Birmingham :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

View More »

Birmingham : Birmingham Psychiatry Pharmaceutical Studies, Inc.

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Birmingham : Birmingham Research Group

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Birmingham : US009

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Birmingham : Birmingham Psychiatry Pharmaceutical Studies, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Birmingham : UAB

Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation

Birmingham : Forest Investigative Site 036

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Birmingham : Forest Investigative Site 021

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Birmingham : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Birmingham : Birmingham Psychiatry Pharmaceutical Studies, Inc

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Dothan : Harmonex

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Dothan : Dothan Behavioral Medicine Clinic

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Dothan : Harmonex

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Dothan : Dothan Behavioral Medicine Clinic

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Dothan : Forest Investigative Site 016

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Tucson : Radiant Research - Tucson

New Clinical Research Study for Depression

View More »

Phoenix : Dedicated Clinical Research

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Phoenix : Dedicated Clinical Research

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Phoenix : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Scottsdale : ResearchOne, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Tucson : University of Arizona Clinical and Translational Science Center (CATS)

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Tucson : University of Arizona College of Medicine Department of Psychiatry

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Tucson : Genova Clinical Research

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Tucson : University of Arizona Clinical and Translational Science Center

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Tucson : University of Arizona College of Medicine Department of Psychiatry

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Tucson : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Tucson : Forest Investigative Site 032 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Tucson :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Tucson :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Fayetteville : Forest Investigative Site 027

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials, P.A.

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials, P.A.

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Little Rock : Forest Investigative Site 029 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Little Rock : Forest Investigative Site 018 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

View More »

Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials, P.A.

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Little Rock : K&S Professional Research Services, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials, P.A.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Arcadia : Pacific Clinical Research Medical Group

Depressed? Not Happy With Your Antidepressant?

Arcadia : Pacific Clinical Research Medical Group

Depressed? Sad? Unmotivated?

Cerritos : Comprehensive Clinical Development - Cerritos, CA

Depression ITN# 11336

Colton : SHANTI Clinical Trials

Depression

Encino : Pharmacology Research Institute, Encino

A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients with Major Depressive Disorder

Encino : Pharmacology Research Institute, Encino

Studies with investigational antidepressant medications for men and women 18 years and older.

Imperial : Sun Valley Research Center

Have you been diagnosed with Depression and your current medication is not working as it should?

Imperial : Sun Valley Research Center

Patients with Major Depressive Disorder

Los Alamitos : Pharmacology Research Institute, Los Alamitos

A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients with Major Depressive Disorder

Los Alamitos : Pharmacology Research Institute, Los Alamitos

Outpatient study for an investigation medication for depression

Los Alamitos : Pharmacology Research Institute, Los Alamitos

Studies with investigational antidepressant medications for men and women 18 years and older.

Newport Beach : Pharmacology Research Institute, Newport Beach

A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients with Major Depressive Disorder

Newport Beach : Pharmacology Research Institute, Newport Beach

Studies with investigational antidepressant medications for men and women 18 years and older.

Orange : Pacific Clinical Research Medical Group

Being a Kid is Hard Enough without having to deal with DEPRESSION

Orange : Pacific Clinical Research Medical Group

Depressed? Clinical Research Trial for Depression Now Enrolling in Orange, CA.

Sherman Oaks : California Neuroscience Research Medical Group, Inc.

Clinical research study of an investigational medication for Major Depressive Disorder.

Sherman Oaks : Schuster Medical Research Institute

Clinical Research Study of an investigational medication for treatment resistant Major Depressive Disorder

Sherman Oaks : Schuster Medical Research Institute

Do you suffer from Bipolar Depression?

Sherman Oaks : Schuster Medical Research Institute

Research study of an investigational medication for Major Depression Disorder with partial response to antidepressants SSRI

Sherman Oaks, : California Neuroscience Research Medical Group, Inc.

Clinical research study of an investigational medication vs. placebo added to a standard antidepressant treatment in persons with Major Depression.

Upland : Pacific Clinical Research Medical Group

Depressed?

Upland : Pacific Clinical Research Medical Group, Upland CA

Depressed? Sad? Clinical Trial for Depression Now Enrolling in Upland, CA

Upland : Pacific Clinical Research Medical Group

Depressed? Clinical Research Trial for Depression Now Enrolling in Upland, CA

Wildomar : Elite Clinical Trials, Inc.

Are you depressed? Do you feel like you just can't get beyond your depression?

View More »

Anaheim :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Anaheim : South Coast Clinical Trials

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Anaheim : South Coast Medical Associates/SC Clinical Trials, Inc.

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Arcadia : Pacific Clinical Research Medical Group

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Arcadia : US010

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Arcadia : Pacific Clinical Research Medical Group

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Arcadia : Forest Investigative Site 050 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Arcadia : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Beverly Hills : Southwest Research, Inc.

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Beverly Hills : Forest Investigative Site 030

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Beverly Hills : Forest Investigative Site 009

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Beverly Hills : Forest Investigative Site 030

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Beverly Hills : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Carson : AV Institue, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Carson :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Cerritos :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Cerritos : Forest Investigative Site 029

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Cerritos : Forest Investigative Site 018

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Cerritos : Comprehensive NeuroScience

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Chino : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Chino :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Chino : Catalina Research Institute, Llc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Chino : Catalina Research Institute, Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Chino : Forest Investigative Site 012

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Chino : Stephen M. Mohaupt, MD

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Colton : Shanti Clinical Trials

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Costa Mesa : ATP Clinical Research, Incorporated

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Costa Mesa : ATP Clinical Research, Incorporated

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Costa Mesa : ATP Clinical Research, Inc.

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Costa Mesa : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Costa Mesa :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Costa Mesa :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Costa Mesa : Gustavo Alva, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Costa Mesa : Forest Investigative Site 022

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Costa Mesa : Forest Investigative Site 002

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Costa Mesa : Forest Investigative Site 028

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Costa Mesa : Clinical Innovation, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Costa Mesa : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Downey : Diligent Clinical Trials

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Downey : Elizabeth Zarate-Rowell, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Encino :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Encino : Pharmacology Research Institute

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Encino : Forest Investigative Site 003

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Escondido : Synergy Clinical Research Center

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Escondido :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Escondido : Synergy Clinical Reserach Center of Escondido

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Garden Grove : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Garden Grove :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Garden Grove :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Garden Grove : Collaborative Neuroscience Network, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Garden Grove : Forest Investigative Site 077 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Garden Grove : Call for Information (Investigational Site 0042)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)

Garden Grove : Collaborative Neuroscience Network, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Glendale : Behavioral Research Specialists, LLC

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Glendale : Behavioral Research Specialists, LLC

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Glendale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Glendale : Behavioral Research Specialists, Llc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Glendale :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Glendale : Behavioral Research Specialists, Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Glendale : California Clinical Trials

Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects

Glendale : Clinical Site

Pharmacokinetics - Pharmacodynamic Study of HT-2157 in Healthy Subjects and in Patients With Major Depressive Disorder

Glendale : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Imperial : Sun Valley Research Center

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Imperial : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Imperial :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Imperial : Sun Valley Behavioral Medical

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Irvine : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Irvine :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Irvine : University of California, Irvine Child Development Center

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Irvine : Irvine Center for Clinical Research

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

La Habra : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

La Habra : Omega Clinical Trials

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Lond Beach : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Long Beach : Veterans Affairs Long Beach Healthcare System

Vilazodone for the Treatment of Posttraumatic Stress Disorder

Los Alamitos : Pharmacology Research Institute

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Los Angeles :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Los Angeles : Forest Investigative Site 017

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Los Angeles : Andrew F. Leuchter, MD

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Los Angeles : UCLA Depression Research & Clinic Program

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Los Angeles : UCLA Semel Institute

Vilazodone for Treatment of Geriatric Depression

Mission Viejo : A.D.D. Treatment Center

International Study to Predict Optimised Treatment - in Depression

Murrieta : Forest Investigative Site 019

Safety and Efficacy of Vilazodone in Major Depressive Disorder

National City : Synergy Clinical Research Center

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

National City : Synergy Clinical Research Center

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

National City : Synergy Clinical Research Center

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

National City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

National City : US001

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

National City : Forest Investigative Site 019 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

New port Beach : Forest Investigative Site 010

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Newport Beach : Forest Investigative Site 022 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Newport Beach :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Newport Beach : Pharmacology Research Institute

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Newport Beach : Forest Investigative Site 005

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Norwalk : South Coast Clinicals

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Norwalk :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Oakland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Oakland :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Oakland : Pacific Research Partners, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Oakland :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Oceanside : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Oceanside : Forest Investigative Site 004 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Oceanside :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Oceanside : North County Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Oceanside :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Oceanside : Forest Investigative Site 039 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Oceanside : Forest Investigative Site 025

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Oceanside : Forest Investigative Site 015

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Oceanside : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Oceanside : North County Clinical Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Orange : Pacific Clinical Research Medical Group

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Orange : Pacific Clinical Research Medical Group

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Orange : Pacific Clinical Research Medical Group

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Orange :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Orange : US007

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Orange : Pacific Clinical Research Medical Group

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Orange : Forest Investigative Site 043

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Palo Alto :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Palo Alto : Stanford -VA Palo Alto Health Care System

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Palo Alto : Stanford -VA Palo Alto Health Care System

Major Depressive Disorder With Mixed Features - Extension

Paramount :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Paramount :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Pasadena : Pasadena Research Institute, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Pico Rivera : CNRI Los Angeles LLC

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Redlands : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Redlands : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Redlands :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Redlands : Anderson Clinical Research

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Redlands : Anderson Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Redlands : Anderson Clinical Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Redlands : Forest Investigative Site 008 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Redlands : Call for Information (Investigational Site 0027)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)

Redlands : Forest Investigative Site 003

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Riverside : Forest Investigative Site 027

Safety and Efficacy of Vilazodone in Major Depressive Disorder

San Bernardino : South Coast Clinical Trials, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Bernardino :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

San Diego : South Bay Research Center

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

San Diego : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

San Diego : Forest Investigative Site 007 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

San Diego : Forest Investigative Site 054 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

San Diego :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

San Diego :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

San Diego : Affiliated Research Institute

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : Artemis Institute For Clinical Research

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : Sharp Mesa Vista Hospital

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : Affiliated Research Institute

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Diego : Clinical Innovations, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Diego : Sharp Mesa Vista Hospital

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Diego : Affiliated Research Institute

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : Pacific Research Network

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : Artemis Institute For Clinical Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : California Neuropsychopharmacology Clinical

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : Sharp Mesa Vista Hospital

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

San Diego : Forest Investigative Site 022

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

San Diego : Ildiko Kovacs, MD

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Diego : PCSD - Feighner Research

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Diego : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

San Diego : CNRI-San Diego LLC

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

San Diego : UCSD Medical Center

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

San Francisco : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Santa Ana : Neuropsychiatric Research Center of Orange County

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Santa Ana : Clinical Innovations, Inc.

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Santa Ana : Neuropsychiatric Research Center of Orange County

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Santa Ana : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Santa Ana : Neuropsychiatric Research Center Of Orange County

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Santa Ana :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Santa Ana : Neuropsychiatric Research Center Of Orange County

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Santa Ana :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Santa Ana : Forest Investigative Site 015 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Santa Ana : Neuropsychiatric Research Center of Orange County

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Santa Ana : Clinical Innovations Inc.

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Sherman Oaks : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Sherman Oaks : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Sherman Oaks : California Neuroscience Research Medical Group, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Sherman Oaks : Schuster Medical Research Institute

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Sherman Oaks : Forest Investigative Site 066 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Sherman Oaks : Forest Investigative Site 046

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Sherman Oaks : Thomas M. Shiovitz, MD

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Sherman Oaks : Schuster Medical Research Institute

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Sherman Oaks : Schuster Medical Research Institute

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Stanford : Stanford University

International Study to Predict Optimised Treatment - in Depression

Stanford : Veteran Affairs/Stanford University

International Study to Predict Optimised Treatment - in Depression

Stanford : Stanford University Medical Center

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Tarzana : Center for Healing the Human Spirit

International Study to Predict Optimised Treatment - in Depression

Temecula : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Temecula : Forest Investigative Site 031 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Temecula : Forest Investigative Site 011

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Temecula : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Temecula : Viking Clinical Research Center

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Torrance :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Torrance : US004

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Torrance : UCLA-Harbor

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Torrence : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Upland : Pacific Clinical Research Medical Group

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Upland : Pacific Clinical Research Medical Group

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Upland : Forest Investigative Site 057

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Wildomar : Elite Clinical Trials, Incorporated

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Wildomar : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Wildomar : Elite Clinical Trials, Incorporated

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Wildomar :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Wildomar :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Denver : Radiant Research - Denver

Clinical Research for Depression

Denver : Radiant Research - Denver

Research Study for Depression

Denver : Radiant Research - Denver

Still Depressed?

View More »

Aurora : Children's Hospital Colorado

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Aurora : The Children's Hospital

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Centennial : Updated

A Study of Ketamine in Patients With Treatment-resistant Depression

Colorado Springs : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Colorado Springs : MCB Clinical Research Centers

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Colorado Springs :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Denver : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Denver : Radiant Research, Inc.

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Denver : Forest Investigative Site 048 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Denver : Western Affiliated Research Institute

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Denver : Radiant Research, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Denver : Western Affiliated Research Institute

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Denver : Western Affiliated Research Institute

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Hartford : Hartford Hospital - Institute of Living

Experiencing Depression Symptoms?

Hartford : Hartford Hospital - Institute of Living

The purpose of this research study is to evaluate the efficacy (how well the drug works), safety (the side effects), and tolerability (how well tolerated) of vilazodone compared to placebo (an inactive substance or sugar pill) in patients with depression.

Waterbury : Chase Medical Research, LLC

A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients with Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment.

View More »

Cromwell : Connecticut Clinical Research

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Cromwell : Connecticut Clinical Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Cromwell : Forest Investigative Site 034

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Cromwell : Forest Investigative Site 016

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Cromwell : Connecticut Clinical Research

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Farmington : University of Connecticut Health Center

Study of Technology-assisted Treatment of Adolescent Depression

Hamden : Geriatric and Adult Psychiatry, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Hartford : Updated

A Study of Ketamine in Patients With Treatment-resistant Depression

Hartford : Institute of Living

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Hartford : Hartford Hospital Institute of Living

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Middletown : Middlexex Hospital Center for Behavioral Health

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

New Britain : The Hospital of Central Connecticut, Psychiatry & Behavioral Health Research

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

New Haven : Yale Depression Research Program

Cortical GABA Concentrations in Subjects With Primary Insomnia and Depression in Partial Remission With Residual Insomnia

New Heaven : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Norwalk :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Norwalk :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Norwalk : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Norwich : Comprehensive Psychiatric Care

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Norwich :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Norwich : Comprehensive Psychiatric Care

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Waterbury : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Wilmington : Christiana Care Health Services

Patient-Centered Depression Care for African Americans

Washington :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Washington :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Washington : US003

Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder

Washington DC : Comprehensive NeuroScience

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Maitland : Florida Clinical Research Center - Orlando/Maitland

Are you Depressed?

Maitland : Florida Clinical Research Center - Orlando/Maitland

Depression getting you down?

Miami : Pharmax Research Clinic, Inc.

Depression Disorder

Pinellas Park : Radiant Research - St. Petersburg

Research Opportunity (Heat Patch)

St. Petersburg : Comprehensive Clinical Development - St. Petersburg, FL

Depression ITN# 12040

St. Petersburg : Comprehensive Clinical Development - St. Petersburg, FL

Depression ITN# 12040

St. Petersburg : Comprehensive Clinical Development - St. Petersburg, FL

Depression ITN# 12040

View More »

Aventura : Scientific Clinical Research, Inc.

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Boca Raton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Bradenton : Florida Clinical Research Center, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Bradenton : Florida Clinical Research Center

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Brooksville : Meridien Research

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Brooksville : Meridien Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Clearwater : Innovative Research of West Florida, Inc.

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Clearwater : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Coral Gables : Sanitas Research

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Coral Gables : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Coral Gables : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Coral Springs :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Coral Springs : CNS Clinical Research Group

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Coral Springs : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Destin : SJS Clinical Research

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Destin : SJS Clinical Research, Inc.

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Doral : Forest Investigative Site 020

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Fort Lauderdale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Fort Myers : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Fort Myers : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Fort Myers : Gulfcoast Clinical Research Center

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Fort Myers : Forest Investigative Site 006

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Fort Myers : Forest Investigative Site 038

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Fort Myers : Gulfcoast Clinical Research Center

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Fort Walton Beach : Emerald Coast Mood & Memory, PA

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Ft. Lauderdale : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Ft. Lauderdale : Forest Investigative Site 007

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Gainesville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Gainesville : Sarkis Clinical Trials

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Gainesville :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Gainesville : Sarkis Clinical Trials

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Gainsville : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Gainsville : Forest Investigative Site 018

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Hallandale Beach : Call for Information (Investigational Site 0036)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)

Hallandale Beach : Forest Investigative Site 055

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Hallandale Beach : Forest Investigative Site 004

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Hialeah : Amedica Research Institute, Incorporated

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Hialeah : Amedica Research Institute, Incorporated

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Hollywood : Segal Institute for Clinical Research

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Jacksonville : Clinical Neuroscience Solutions, Inc.

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Jacksonville : Clinical Neuroscience Solution, Inc.

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Jacksonville : Clinical Neuroscience Solutions, Inc.

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Jacksonville :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Jacksonville : Amit Vijapura

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Jacksonville : Amit Vijapura

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Jacksonville : Clinical Neuroscience Solutions, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Jacksonville : Forest Investigative Site 029 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Jacksonville : Forest Investigative Site 063

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Jacksonville : Forest Investigative Site 005

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Jacksonville : Forest Investigative Site 012

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Jacksonville : Amit Vijapura MD

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Jacksonville : Clinical Neuroscience Solutions, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Jacksonville : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Jacksonville : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Jacksonville : Clinical Neuroscience Solutions Inc

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Jacksonville Beach : Forest Investigative Site 008

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Jacksonville Beach : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Jacksonville Beach : George M. Joseph, MD & Associates, Inc.

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Juno Beach : Advanced Mental Health Care Inc. - Juno Beach

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Kissimmee : Accurate Clinical Trials

Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder

Kissimmee : Forest Investigative Site 012 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Lake City : Forest Investigative Site 063 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Lake City : Psychiatric Associates

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Lauderhill : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Lauderhill :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Lauderhill :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Lauderhill :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Lauderhill : Fidelity Clinical Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Lauderhill : Fidelity Clinical Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Leesburg : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Leesburg : Forest Investigative Site 006 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Leesburg : Compass Research, LLC: North Clinic

Efficacy of Electronic Cognitive Behavioral Therapy Application to Treat Major Depressive Disorder

Leesburg : Forest Investigative Site 015

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Maitland : Florida Clinical Research Center

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Maitland : Florida Clinical Research Center, LLC.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Maitland : US006

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Melbourne : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Miami : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Miami : Forest Investigative Site 026 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Miami :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Miami :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Miami : US003

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Miami : University of Miami

International Study to Predict Optimised Treatment - in Depression

Miami : Miami Jewish Health System

Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder

Miami : Forest Investigative Site 035

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Miami Springs : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

New Port Richey : Suncoast Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

North Bay Village : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

North Miami : Forest Investigative Site 027 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

North Miami :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

North Miami :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

North Miami : Scott Daniel Segal, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

North Miami : David H. Flaherty, DO

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

North Miami : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

Oakland Park : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Ocala :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Orange City :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Orlando : Ali A. Kashfi, MD

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Orlando : Clinical Neuroscience Solutions Incorporated

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Orlando : Clinical Neuroscience Solutions, Inc

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Orlando : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Orlando : Ali A. Kashfi, MD

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Orlando : Clinical Neuroscience Solutions Incorporated

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Orlando : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Orlando :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Orlando : Compass Research, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Orlando : Clinical Neuroscience Solutions, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Orlando :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Orlando : Clinical Neuroscience Solutions, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Orlando : Compass Research, Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Orlando : Forest Investigative Site 026 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Orlando : Forest Investigative Site 030

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Orlando : Forest Investigative Site 062

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Orlando : Forest Investigative Site 004

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Orlando : Forest Investigative Site 035

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Orlando : Ali A. Kashfi, MD, PA

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Orlando : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Orlando : Compass Research, LLC

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Pembroke Pines : Forest Investigative Site 045

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Plantation : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Royal Palm Beach : Advanced Mental Health Care Inc. - Royal Palm Beach

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Sanford : Medical Research Group of Central Florida

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Sanford :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Sanford :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

South Miami : Forest Investigative Site 044 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

St Petersburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

St Petersburg : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

St Petersburg : Comprehensive Clinical Development, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

St. Petersburg : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

St. Petersburg : Comprehensive NeuroScience, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

St. Petersburg : Meridien Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

St. Petersburg :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Tampa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Tampa : Stedman Clinical Trials

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Tampa :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Tampa : Stedman Clinical Trials

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Tampa :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Tampa : Forest Investigative Site 051

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Tampa : University of South Florida

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Tampa : Stedman Clinical Trials, LLC

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

University Park : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

West Palm Beach : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

West Palm Beach :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

West Palm Beach : Janus Center For Psychiatric Research

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

West Palm Beach : Janus Center for Psychiatric Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

West Palm Beach :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

West Palm Beach : Janus Center For Psychiatric Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

West Palm Beach : Forest Investigative Site 032

Safety and Efficacy of Vilazodone in Major Depressive Disorder

West Palm Beach : Forest Investigative Site 001

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Winter Haven : Clinical Research of Central Florida

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Winter Park : Kolin Research Group

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Winter Park : Kolin Research Group

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Winter Park : Winter Park Memorial Hospital

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Winter Park : Forest Investigative Site 019 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Winter Park : Forest Investigative Site 022

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Winter Park : Forest Investigative Site 013

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Winter Park : Kolin Research Group

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Winterpark : Winter Park Memorial Hospital

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Atlanta : Mood and Anxiety Disorders Program of Emory University

Have you been feeling sad or down nearly every day over the past month?

Atlanta : Mood and Anxiety Disorders Program of Emory University

How are you feeling?

Stockbridge : Mood and Anxiety Disorders Program of Emory University

Have you been feeling sad or down nearly every day over the past month?

View More »

Atlanta : Atlanta Center for Medical Research

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Atlanta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Atlanta : Atlanta Center for Medical Research

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Atlanta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Atlanta : Atlanta Center for Medical Research

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Atlanta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Atlanta : Updated

A Study of Ketamine in Patients With Treatment-resistant Depression

Atlanta : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Atlanta : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Atlanta : Forest Investigative Site 024 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Atlanta :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Atlanta :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Atlanta : Emory University

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Atlanta : Atlanta Institute of Medicine & Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Atlanta : Comprehensive Neuroscience, Inc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Atlanta : Emory University

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Atlanta :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Atlanta : Emory University

Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression

Atlanta : Forest Investigative Site 062 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Atlanta : Forest Investigative Site 060

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Atlanta : Forest Investigative Site 012

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Atlanta : Forest Investigative Site 005

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Atlanta : Forest Investigative Site 038

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Atlanta : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Atlanta : Atlanta Center for Medical Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Atlanta : Atlanta Center for Medical Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Marietta : Northwest Behavioral Research Center

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Marietta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Marietta : Northwest Behavioral Research Center/Northwest Behavioral Medicine

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Roswell :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Smyma : Forest Investigative Site 065 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Smyrna : Institute for Behavioral Medicine, LLC

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Smyrna : Institute for Behavioral Medicine, LLC

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Smyrna :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Smyrna : Carman Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Smyrna : Carman Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Smyrna : Call for Information (Investigational Site 0028)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)

Smyrna : Institute for Behavioral Medicine, LLC

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Smyrna : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Smyrna : Carman Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Honolulu : Hawaii Clinical Research Center

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Chicago : Rush University Medical Center - Treatment Research Center

Do you suffer from Depression?

Chicago : Rush University Medical Center - Treatment Research Center

Preventing the Recurrence of Depression in Bipolar Disorder

Chicago : Chicago Research Center, Inc

This research will evaluate the safety, tolerability and efficacy of an experimental drug, Levomilnacipran, sustained release (SR) compared to placebo (inactive substance) in the potential treatment of depression in people with Major Depressive Disorder.

Skokie : Psychiatric Medicine Associates/John Zajecka, M.D.

Depression Research Study

Skokie : Psychiatric Medicine Associates/John Zajecka, M.D.

Depression Research Study for adults who are currently taking an antidepressant but still experiencing some symptoms of depression

Skokie : Rush University Medical Center - Treatment Research Center

Depression Study. A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo- Controlled, Phase III, Efficacy and Safety Study of 3 Fixed Dose Groups of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressant in Patients with Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy

View More »

Chicago :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Chicago :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Chicago : Richard S. Abrams, MD- Psychiatry

Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AT1)

Chicago : Colette Bostin-Gordon, MD

Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AT1)

Chicago : Rush Medical College

Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression

Chicago : Call for Information (Investigational Site 0029)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)

Chicago : Forest Investigative Site 037

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Chicago : Forest Investigative Site 050

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Chicago : Forest Investigative Site 029

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Chicago : Corey N. Goldstein, MD

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Chicago : TMS Specialists Chicago

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Hoffman Estates : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Hoffman Estates : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Hoffman Estates : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Hoffman Estates : Forest Investigative Site 013 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Hoffman Estates :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Hoffman Estates : Forest Investigative Site 019

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Hoffman Estates : Alexian Brothers Center for Psychiatric Research

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Joliet : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Joliet :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Libertyville : Capstone Clinical Research

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Libertyville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Libertyville : Capstone Clinical Research

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Naperville : AMR-Baber Research Inc.

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Naperville : AMR Baber Research

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Naperville : AMR-Baber Research Inc.

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Naperville :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Oak Brook : American Medical Research, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Oak Brook :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Oak Brook :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Oakbrook Terrace : Midwest Center for Neurobehavioral Medicine

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Park Ridge : CNS - Comprehensive Neuro Science

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Skokie : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Skokie :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Skokie : Psychiatric Medicine Associates, LLC

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Stokie : Psychiatric Medicine Associates

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Vernon Hills : Sleep and Behavior Medicine Institute

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Indianapolis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Indianapolis : The Davis Clinic

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Indianapolis :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Indianapolis : Forest Investigative Site 040

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Indianapolis : Forest Investigative Site 021

Safety and Efficacy of Vilazodone in Major Depressive Disorder

View More »

Indianapolis : Forest Investigative Site 024

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Indianapolis : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Lafayette : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Lafayette : Forest Investigative Site 042 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Lafayette : Alpine Clinic

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Lafayette : Forest Investigative Site 012

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Lafayette : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Lafayette : Alpine Clinic

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Newburgh : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Newburgh : Pedia Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Terre Haute : Clinco

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Terre Haute : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Terre Haute : Clinco

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Terre Haute : Clinco

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Terre Haute : Clinco

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Valparaiso : Northwest Indiana Center for Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Overland Park : Psychiatric Associates

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Overland Park : Psychiatric Associates

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Prairie Village : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Prairie Village : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Prairie Village :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

View More »

Prairie Village :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Prairie Village : Clinical Trials Technology, Inc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Prairie Village : Forest Investigative Site 074 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Prairie Village : Call for Information (Investigational Site 0041)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)

Prairie Village : Forest Investigative Site 053

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Prairie Village : Forest Investigative Site 031

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Prairie Village : Clinical Trials Technology, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Prairie Village : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

Prairie Village : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Wichita : Heartland Research Associates, LLC

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Wichita : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Wichita :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Wichita : Heartland Research Associates

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Wichita : US004

Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder

Wichita : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Edgewood : OtriMed Clinical Research

Adult Major Depressive Disorder Clinical Trial

Lexington : Kentucky Medical Research

Depression

View More »

Crestview Hills : Community Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Florence : MCM Clinical Research LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Lexington : Central Kentucky Research Associates, Inc.

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Lexington : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Owensboro : Pedia Research, LLC

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Lake Charles : Lake Charles Clinical Trials

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Lake Charles : Lake Charles Clinical Trials

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Lake Charles : Lake Charles Clinical Trials

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Lake Charles : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Lake Charles :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

View More »

New Orleans : James G. Barbee, Md, Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

New Orleans : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Shreveport : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Shreveport : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Shreveport :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Shreveport : J. Gary Booker, Md, Apmc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Shreveport :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Shreveport : Louisiana Clinical Research, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Shreveport :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Shreveport : J. Gary Booker, Md, Apmc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Shreveport :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Gaithersburg : Potomac Grove Clinical Research Center

An Investigational Medication for Major Depressive Disorder

Gaithersburg : Potomac Grove Clinical Research Center

Major Depressive Disorder and Sexual Dysfunction

View More »

Baltimore : Pharmasite Research Inc

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Baltimore : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Baltimore : Pharmasite Research Inc

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Baltimore : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Baltimore : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Baltimore : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Baltimore :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Baltimore : Pharmasite Research, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Baltimore :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Baltimore : Johns Hopkins University

Lexapro for the Treatment of Traumatic Brain Injury (TBI) Depression & Other Psychiatric Conditions

Baltimore : Johns Hopkins School of Medicine

Patient-Centered Depression Care for African Americans

Baltimore : Sinai Hospital

Patient-Centered Depression Care for African Americans

Baltimore : Baltimore Medical Systems, Middlesex Health Center

Patient-Centered Depression Care for African Americans

Baltimore : Johns Hopkins Community Phsyicians

Patient-Centered Depression Care for African Americans

Baltimore : Sheppard Pratt Health System

Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1)

Baltimore : Call for Information (Investigational Site 0033)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)

Baltimore : Forest Investigative Site 020

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Baltimore : Johns Hopkins University

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Baltimore : Forest Investigative Site 001

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Baltimore : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Baltimore : Sheppard Pratt Health System

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Gaithersburg : Forest Investigative Site 049 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Gaithersburg :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Gaithersburg : Potomac Grove Clinical Research Center

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Glen Burnie : Clinical Insights

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Rockville : Neuroscientific Insights

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Rockville : Updated

A Study of Ketamine in Patients With Treatment-resistant Depression

Rockville : Office of Marc Hertzman, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Towson : Forest Investigative Site 001

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Brighton : Boston Clinical Trials

Do you often feel sad, down and unmotivated? Have you been taking medication for depression but still have symptoms?

Brighton : Boston Clinical Trials

I Feel Blue…

Brighton : Boston Clinical Trials

Stuck with Depression? You are not alone.

Haverhill : ActivMed Practices & Research, Inc.

Are you between the ages of 18 and 65 and suffering from Depression?

Haverhill : ActivMed Practices & Research, Inc.

Are you or a loved one suffering from symptoms of Bipolar Disorder?

Haverhill : ActivMed Practices & Research, Inc.

Has your depression got you feeling down? Are you having trouble concentrating on your tasks?

Haverhill : ActivMed Practices & Research, Inc.

Has your depression got you feeling down? Are you having trouble concentrating on your tasks?

View More »

Belmont : Mclean Hospital

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Belmont : McLean Hospital - McLean Imaging Center

Functional and Neurochemical Correlates of Treatment Response in Major Depressive Disorder

Belmont : McLean Hospital

Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder (MDD) Partly Responsive to Selective Serotonin Reuptake Inhibitor (SSRI) or Selective Norepinephrine Reuptake Inhibitor (SNRI) Treatment

Belmont : Mclean Hospital

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Belmont : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Boston : Boston Clinical Trials

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Boston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Boston : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Boston : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Boston : Forest Investigative Site 046 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Boston :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Boston : Massachusetts General Hospital

Escitalopram (Lexapro) for the Treatment of Postpartum Depression

Boston : Massachusetts General Hospital

Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability

Boston : Massachusetts General Hospital - Center for Anxiety and Traumatic Stress Disorders

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Boston : Massachusetts General Hospital - Center for Anxiety and Traumatic Stress Disorders

Major Depressive Disorder With Mixed Features - Extension

Boston : Forest Investigative Site 031

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Boston : Forest Investigative Site 003

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Boston : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Boston : Massachusetts General Hospital- Depression Clinical and Research Program

Transcranial Laser Therapy for Major Depressive Disorder

Cambridge : Cambridge Health Alliance

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Cambridge : Cambridge Health Alliance

Ropinirole in the Treatment of Bipolar Depression

Chelsea : Chelsea Counseling Center- North Suffolk Mental Health Association

Transcranial Laser Therapy for Major Depressive Disorder

Fall River : AccelRx Research

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Fall River : AccelRx Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Haverhill : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Haverhill : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Haverhill :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Haverhill : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Watertown : Adams Clinical Trials, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Watertown : Adams Clinical Trials LLC

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Weymouth : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Weymouth :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Weymouth : Forest Investigative Site 013

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Weymouth : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Woburn : Woburn Pediatric Associates

Study of Technology-assisted Treatment of Adolescent Depression

Ann Arbor : Michigan Head Pain and Neurological Institute

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Rochester Hills : Forest Investigative Site 028

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Rochester Hills : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Rochester : Mayo College of Medicine

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Flowood : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Flowood :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Flowood :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Flowood :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Flowood : Forest Investigative Site 040 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

View More »

Flowood : Precise Research Centers

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Are you down in the dumps with your diabetes?

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Depression Research Study Seeks Volunteers with Heart Failure.

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Pre-diabetes: Are you at risk?

View More »

Creve Coeur : Millennium Psychiatric Associates, LLC

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Creve Coeur : Millennium Psychiatric Associates, LLC

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Creve Coeur :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Creve Coeur : Forest Investigative Site 068 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Creve Coeur : Forest Investigative Site 026

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Creve Coeur : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Gladstone : Asim Ulusarac, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Kansas City : The Center for Pharmaceutical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

O'Fallon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

O'Fallon : Howard J. Ilivicky, MD

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

St Louis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

St Louis :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

St. Charles : St. Charles Psychiatric Associates - Midwest Research Group

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

St. Charles : St Charles Psychiatric Associates

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

St. Charles : Midwest Chest Consultants

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

St. Charles : St. Charles Psychiatric Associates - Midwest Research Group

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

St. Charles : St. Charles Psychiatric Associates - Midwest Research Group

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

St. Louis : Scientella LLC

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

St. Louis : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

St. Louis :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

St. Louis : Mercy Health Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

St. Louis :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

St. Louis : St. Louis Clinical Trials

Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder

St. Louis : Mid-America Clinical Research, LLC

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

St. Louis : Washington University School of Medicine

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Lincoln : Premier Psychiatric Research Institute, LLC

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Lincoln : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Lincoln : Premier Psychiatric Research Institute, LLC

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Lincoln : Premier Psychiatric Research Institute, LLC.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

North Platte : Heartland Pharma Development

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

View More »

North Platte :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Omaha : Quality Clinical Research, Inc.

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Omaha : Creighton University, Department of Psychiatry

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Omaha : University of Nebraska Medical Center

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Las Vegas : Center for Psychiatry and Behavioral Medicine, Incorporated

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Las Vegas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Las Vegas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Las Vegas : Center for Psychiatry and Behavioral Medicine, Incorporated

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Las Vegas :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

View More »

Las Vegas : Forest Investigative Site 037

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Las Vegas : Clinical Research Consortium

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Keene : Family Medicine Clinics, Cheshire Medical Center (DH-Keene)

Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E Trial

Nashua : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Cherry Hill : Center For Emotional Fitness

DEPRESSION

Cherry Hill : University of Medicine and Dentistry of New Jersey - School of Osteopathic Medicine

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Mount Laurel : CRI Lifetree

Do you or a loved one suffer from Depression?

New Brunswick : UMDNJ-Robert Wood Johnson Medical School

Coping With Depression in Parkinson's Disease

View More »

Berlin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Berlin : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Cherry Hill : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Cherry Hill :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Cherry Hill : Forest Investigative Site 061 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Cherry Hill : Forest Investigative Site 023

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Cherry Hill : Center for Emotional Fitness

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Cherry Hill : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Cherry Hill : Center for Mood Disorders and Neuromodulation Therapies, UMDNJ-SOM

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Marlton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Marlton : CRI Lifetree

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Mount Laurel : CRI Worldwide, LLC

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Princeton : Global Medical Institutes

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Princeton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Toms River :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Toms River : Bio Behavioral Health

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Toms River : Bio Behavioral Health

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Toms River : Bio Behavioral Health

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Toms River : Call for Information (Investigational Site 0035)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)

Voorhees : Amita Talati- MD

Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AT1)

Willingboro : CRI Worldwide, LLC

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Willingboro :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Willingboro : Forest Investigative Site 038 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Willingboro : Forest Investigative Site 024

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Willingboro : Forest Investigative Site 014

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Willingboro : CRI Worldwide LLC

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Albuquerque : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Albuquerque : Forest Investigative Site 058 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Albuquerque :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Albuquerque :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Albuquerque : Albuquerque Neuroscience, Inc.

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

View More »

Albuquerque : Albuquerque Neuroscience, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Albuquerque : Forest Investigative Site 030 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Albuquerque : Forest Investigative Site 011

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Albuquerque : Forest Investigative Site 010

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Albuquerque : Forest Investigative Site 006

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Albuquerque : Glenn Michael Dempsey, MD

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Albuquerque : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

Bronx : Biomedical Research Alliance of New York

Major Depressive Disorder

New York : Clinilabs, Inc.

Are anti-depression medications just not working for you? (New York, NY)

New York : Medical & Behavioral Health Research, PC

Bipolar Depression

New York : Medical & Behavioral Health Research, PC

Bipolar Depression Research Study

New York : Medical & Behavioral Health Research, PC

Depressed?

New York : Medical & Behavioral Health Research, PC

DEPRESSED? 18-65 YEARS OLD?

New York : Clinilabs, Inc.

Feeling Depressed?

New York : Clinilabs, Inc.

Have you been diagnosed with major depression? Do you continue to have symptoms despite medications?

New York : Clinilabs, Inc.

Have you been diagnosed with major depression? Do you continue to have symptoms despite medications?

New York : Biomedical Research Alliance of New York

Major Depressive Disorder

View More »

Bronx : Montefiore Medical Center

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Brooklyn : Social Psychiatry Research Institute

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Brooklyn : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Brooklyn : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Brooklyn : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Brooklyn : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Brooklyn : Forest Investigative Site 028 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Brooklyn : Brooklyn Medical Institute

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Brooklyn : US014

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Brooklyn : Social Psychiatry Research Institute

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Brooklyn :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Brooklyn : Forest Investigative Site 076 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Brooklyn : Forest Investigative Site 004

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Brooklyn : Forest Investigative Site 003

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Brooklyn : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Brooklyn : Behavioral Medical Research of Brooklyn

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Brooklyn : Behavioral Medical Research of Brooklyn

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Cedarhurst :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Cedarhurst : Neurobehavioral Research, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Cedarhurst :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Cedarhurst : Forest Investigative Site 007

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Fresh Meadows : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Fresh Meadows : Comprehensive Clinical Development, Inc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Fresh Meadows : Comprehensive Clinical Development, Inc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Fresh Meadows : Comprehensive Clinical Development, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Fresh Meadows : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Glen Oaks : The Zucker Hillside Hospital

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Mount Kisco : Bioscience Research, LLC.

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Mount Kisco : Bioscience Research, LLC.

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Mount Kisco : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Mount Kisco : Bioscience Research, Llc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Mount Kisco : Bioscience Research, Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Mount Kisco : Forest Investigative Site 037 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Mt. Kisco : Bioscience Research, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

New York : Mount Sinai School of Medicine

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

New York : Updated

A Study of Ketamine in Patients With Treatment-resistant Depression

New York : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

New York : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

New York : Forest Investigative Site 016 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

New York :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

New York : New York State Psychiatric Institute/Columbus Circle Midtown

Desvenlafaxine vs. Placebo Treatment of Chronic Depression

New York : Depression Evaluation Service (DES), New York State Psychiatric Institute, Columbia University Department of Psychiatry

Desvenlafaxine vs. Placebo Treatment of Chronic Depression

New York : Village Clinical Research, Inc.

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

New York :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

New York : Medical & Behavioral Health Research, PC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

New York : Fieve Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

New York :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

New York : US011

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

New York : US013

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

New York : Weill Medical College of Cornell University

Lexapro for Major Depression in Patients With Epilepsy

New York : Village Clinical Research, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

New York : New York State Psychiatric Institute, 1051 Riverside Drive

Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression

New York : Weill Cornell Medical College

Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines

New York : Jan Roda, MD - Psychiatry

Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AT1)

New York : Forest Investigative Site 067 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

New York : Call for Information (Investigational Site 0039)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)

New York : Forest Investigative Site 047

Safety and Efficacy of Vilazodone in Major Depressive Disorder

New York : Mount Sinai Hospital

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

New York : Forest Investigative Site 025

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

New York : Clinlabs, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

New York : Daniel V. Iosifescu, MD

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

New York : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

New York : Medical and Behavioral Health Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

New York : Fieve Clinical Services, Inc.

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

New York : Medical and Behavioral Health Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

New York : Mount Sinai School of Medicine

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

New York City : Forest Investigative Site 058

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Rochester : Finger Lakes Clinical Research

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Rochester : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Rochester : Finger Lakes Clinical Research

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Rochester : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Rochester :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Rochester :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Rochester : Finger Lakes Clinical Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Staten Island : Behavioral Medical Research of Staten Island

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Staten Island : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Staten Island : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Staten Island :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Staten Island : Richmond Behavioral Associates

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Staten Island :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Staten Island : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Staten Island : Richmond Behavioral Associates

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Staten Island : Behavioral Medical Research of Staten Island

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Staten Island : Richmond Behavioral Associates

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Staten Island : Behavioral Medical Research of Staten Island

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Stony Brook : Stony Brook University Medical Center

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Stony Brook : Stony Brook University Medical Center

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Syracuse : Suny Upstate Medical University

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

West Seneca : Daniel I. Rifkin MD PC

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

White Plains : Weill Cornell Medical College

International Study to Predict Optimised Treatment - in Depression

White Plains : Weill Cornell Medical College-Westchester Division

Treatment Response of Geriatric Depression

Charlotte : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Charlotte : Carolinas Healthcare System

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Charlotte : Carolinas Healthcare System

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Durham : Triangle Neuropsychiatry

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Durham : Psychiatry and Behavioral Sciences, Duke

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

View More »

Durham : Psychiatry and Behavioral Sciences, Duke

Major Depressive Disorder With Mixed Features - Extension

Durham : Forest Investigative Site 014

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Durham : Forest Investigative Site 004

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Durham : Duke University Brain Stimulation and Neurophysiology Center

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Greensboro : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Greensboro : Call for Information (Investigational Site 0034)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)

Hickory : James Barker, MD

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Raleigh :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Raleigh : Rcihard H. Weisler, MD, PA & Associates

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Raleigh : Richard H. Weisler, Md, Pa & Assoc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Raleigh : Call for Information (Investigational Site 0052)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)

Raleigh : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Wilmington : PMG Research of Wilmington

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Winston-salem : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Cincinnati : Community Research

Feeling Depressed?

Cincinnati : Community Research

Not seeing the results you want from your antidepressant?

View More »

Avon lake :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Beachwood : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Beachwood : Northcoast Clinical Trials, Inc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Beachwood :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Beachwood : Northcoast Clinical Trials, Inc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Beachwood : Call for Information (Investigational Site 9089)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)

Beachwood : Bijan Bastani, MD

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Beachwood : North Coast Clinical Trials, Inc.

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Canton : Neuro-Behvioral Clinical Research, Inc.

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Canton : Neuro-Behavioral Clinical Research, Inc

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Canton : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Canton : Forest Investigative Site 047 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Canton : Forest Investigative Site 036

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Canton : Neuro-Behavioral Clinical Research, Inc

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Cincinatti :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Cincinatti : Community Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Cincinnati : Community Research

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Cincinnati : University of Cincinnati

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Cincinnati : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Cincinnati : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Cincinnati : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Cincinnati : Patient Priority Clinical Sites, Llc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Cincinnati : Patient Priority Clinical Sites, Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Cincinnati : Forest Investigative Site 039

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Cincinnati : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Cincinnati : University of Cincinnati

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Cincinnatti : US002

Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder

Cleveland : Discovery and Wellness Center for Children/University Hospitals Case Medical Center

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Cleveland : Discovery and Wellness Center for Children/University Hospitals Case Medical Center

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Cleveland : University Hospitals Case Medical Center

Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance

Columbus : Radiant Research, Inc.

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Columbus : Ohio State University

International Study to Predict Optimised Treatment - in Depression

Columbus : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Dayton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Dayton : Midwest Clinical Research Center

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Dayton : Midwest Clinical Research Center

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Dayton : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Dayton :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Dayton :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Dayton : Bernadette B. D'Souza, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Dayton : Midwest Clinical Research Center

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Dayton : Forest Investigative Site 021 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Dayton : Forest Investigative Site 002

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Dayton : Forest Investigative Site 008

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Dayton : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Garfield Heights :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Mason : Lindner Center of HOPE

Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression

Mason : Lindner Center of HOPE

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Mason : Lindner Center of HOP

Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression

Middleburg Heights : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Middleburg Heights : North Star Medical Research

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Middleburg Heights : North Star Medical Research, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Toledo : Neurology and Neuroscience Center of Ohio

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Toledo :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Toledo : Neurology & Neuroscience Center Of Ohio

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Toledo :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Toledo : Neurology & Neuroscience Center Of Ohio

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Toledo : Neurology & Neuroscience Center of Ohio

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Toledo : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Toledo : Kettlie Joseph Daniels, MD

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Enid : Cutting Edge Research of Enid

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Oklahoma City : Cutting Edge Research Group

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Oklahoma City : IPS Research Company

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Oklahoma City : SP Research, PLLC

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Oklahoma City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

View More »

Oklahoma City : Cutting Edge Research of Enid

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Oklahoma City : IPS Research Company

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Oklahoma City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Oklahoma City : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Oklahoma City :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Oklahoma City : SP Research, PLLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Oklahoma City : Sooner Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Oklahoma City :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Oklahoma City : Ips Research Company

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Oklahoma City : Forest Investigative Site 042

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Oklahoma City : Forest Investigative Site 048

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Oklahoma City : Forest Investigative Site 024

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Oklahoma City : Forest Investigative Site 025

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Oklahoma City : IPS Research Company

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Oklahoma City : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Oklahoma City : Lynn Health Science Institute

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Oklahoma City : Sooner Clinical Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Oklahoma City : IPS Research Company

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Tulsa : Tulsa Clinical Research, Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Portland : Summit Research Network (Oregon), Inc.

Depression Research Study

View More »

Medford : Sunstone Medical Research, LLC

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Portland : Summit Research Network (Oregon), Incorporated

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Portland : Summit Research Network (Oregon), Incorporated

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Portland : Oregon Health & Science University

Circadian Effects of Escitalopram

Portland :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Portland :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Portland : Summit Research Network (Oregon) Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Portland : US012

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Portland : Summit Research Network (Oregon) Inc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Portland : Forest Investigative Site 022 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Portland : Call for Information (Investigational Site 0040)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)

Portland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

Portland : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Portland : Oregon Center for Clinical Investigators, Inc. (OCCI, Inc.)

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Salem : Oregon Center For Clinical Investigations, Inc (Occi, Inc)

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Salem : Forest Investigative Site 027 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Salem : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Media : Suburban Research Associates

Do you suffer from Depression & Pain?

View More »

Allentown : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Allentown : Updated

A Study of Ketamine in Patients With Treatment-resistant Depression

Allentown : Lehigh Center for Clinical Research

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Allentown :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Allentown :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Allentown : Lehigh Center for Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Allentown :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Allentown : Forest Investigative Site 014

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Allentown : Forest Investigative Site 009

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Allentown : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Allentown : Lehigh Center for Clinical Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Allentown : Lehigh Center for Clinical Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Bala Cynwyd : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Bridgeville : Paramount Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Broomall : Southeastern PA Medical Institute

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Jenkintown :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Media : Suburban Research Associates

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Media : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Media : Suburban Research Associates

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Media :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Media : Shivkumar Hatti, MD, MBA

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Media : Suburban Research Associates

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Media : Forest Investigative Site 010

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Norristown : Keystone Clinical Studies, Llc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Norristown :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Norristown : Keystone Clinical Studies, Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Norristown : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Philadelphia : CRI Worldwide

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Philadelphia : University of Pennsylvania

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Philadelphia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Philadelphia : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Philadelphia :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Philadelphia : CRI Worldwide LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Philadelphia : Thomas Jefferson University

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Philadelphia : University Of Pennsylvania

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Philadelphia :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Philadelphia : CRI Lifetree- Philadelphia Research Center

Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder

Philadelphia : Forest Investigative Site 025 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Philadelphia : Forest Investigative Site 011

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Philadelphia : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Philadelphia : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Philadelphia : Belmont Center for Comprehensive Treatment

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Philadelphia : University of Pennsylvania

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Pittsburgh : University of Pittsburgh School of Medicine

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Pittsburgh :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Pittsburgh : Mood Disorders Treatment Research Program University of Pittsburgh-Western Psychiatric Institute and Clinic

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Scranton : Scranton Counseling Center

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

West Chester : University Services

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Wyomissing : Behavioral Medicine Center

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Wyomissing : Clinical Research Center of Reading, LLP

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Lincoln : Lincoln Research - Rhode Island

Announcing a medical research study for adults with DEPRESSION and FATIGUE?

Lincoln : Lincoln Research - Rhode Island

depressed...? Approximately one in 10 people suffer from depression...you are not alone.

Lincoln : Lincoln Research - Rhode Island

Do you feel Depressed? Announcing a medical research study for people with depression.

Lincoln : Lincoln Research - Rhode Island

Is the burden of Depression weighing you down...despite medication?

Lincoln : Lincoln Research - Rhode Island

Suffering from bipolar depression and are depressed and on medication?

View More »

East Greenwich : Costal Medical

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

East Providence : Rhode Island Mood & Memory Research Institute

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Lincoln : Lincoln Research

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Lincoln :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Lincoln : Lincoln Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Lincoln : Call for Information (Investigational Site 0044)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)

Lincoln : Forest Investigative Site 015

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Lincoln : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Providence : Butler Hospital Mood Disorders Research Program, Brown Department of Psychiatry and Human Behavior

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Warwick : Omega Medical Research

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Greer : Radiant Research - Greer

Clinical Research Study for Depression

Mt. Pleasant : Coastal Carolina Research Center

Volunteers who suffer from Fibromyalgia pain and also Depression are needed for a new clinical research study.

View More »

Charleston : Updated

A Study of Ketamine in Patients With Treatment-resistant Depression

Charleston : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Charleston : MUSC Institute of Psychiatry, Brain Stimulation Lab

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Columbia :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Columbia :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Columbia : Carolina Clinical Research Services

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Columbia : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Greer : Radiant Research

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Mount Pleasant : Coastal Carolina Research Center

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

North Charleston : Medical University South Carolina Anxiety Disorder Program

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Memphis : Research Strategies of Memphis

To evaluate safety and efficacy of add on therapy in treatment of Major Depression Disorder

Memphis : Research Strategies of Memphis, LLC

To evaluate safety and efficacy of add on therapy in treatment of Major Depression Disorder

Nashville : Clinical Research Associates

Major Depression

View More »

Franklin : Psychiatric Consultants, PC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Franklin :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Franklin : Psychiatric Consultants, Pc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Memphis : Research Strategies of Memphis, LLC

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Memphis : Clinical Neuroscience Solutions, Incorporated

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Memphis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Memphis : Clinical NeuroScience Solutions, Inc.

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Memphis : Clinical Neuroscience Solutions, Incorporated

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Memphis : Research Strategies of Memphis, LLC

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Memphis :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Memphis : Clinical Neuroscience Solutions, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Memphis : Anita Sudan Varma, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Memphis : Clinical Neuroscience Solutions, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Memphis :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Memphis : Forest Investigative Site 048 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Memphis : Forest Investigative Site 064

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Memphis : Forest Investigative Site 008

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Memphis : Forest Investigative Site 019

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Memphis : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Memphis : Clinical Neuroscience Solutions, Inc.

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Nashville : Vanderbilt University Medical Center

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Nashville : Clinical Research Associates

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Nashville : Centerstone

Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1)

Dallas : Research Across America

Major Depression

Houston : Bayou City Research Corporation

Still Depressed?

San Antonio : Croft Group Research Center

Are you DEPRESSED?

San Antonio : Croft Group Research Center

Are you taking an antidepressant but still depressed?

San Antonio : Radiant Research - San Antonio

Clinical Research for Depression

San Antonio : Croft Group Research Center

Have you had several depressive episodes?

San Antonio : Radiant Research - San Antonio

Research Study for Depression

View More »

Ausitn : Senior Adults Specialty Research

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Austin : FutureSearch Clinical Trials, L.P.

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Austin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Austin : FutureSearch Trials of Neurology

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Austin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Austin : FutureSearch Clinical Trials, L.P.

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Austin : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Austin :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Austin : Future Search Trials

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Austin : FutureSearch Clinical Trials, LP

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Austin : Community Clinical Research, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Austin : Forest Investigative Site 024 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Austin : Forest Investigative Site 013

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Austin : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Austin : FutureSearch Trials of Neurology

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Dallas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Dallas : FutureSearch Trials of Dallas

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Dallas : Updated

A Study of Ketamine in Patients With Treatment-resistant Depression

Dallas : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Dallas : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Dallas :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Dallas :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Dallas : Futuresearch Trials Of Dallas

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Dallas : Future Search Trials of Dallas, LP

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Dallas : KRK Medical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Dallas :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Dallas : Futuresearch Trials Of Dallas

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Dallas : Dept. of Psychiatry, UT Southwestern Medical Center

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Dallas : Dept. of Psychiatry, UT Southwestern Medical Center

Major Depressive Disorder With Mixed Features - Extension

Dallas : Forest Investigative Site 020 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Dallas : Forest Investigative Site 021

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Dallas : Forest Investigative Site 023

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Dallas : UT Southwestern Medical Center at Dallas

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Dallas : Forest Investigative Site 007

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Dallas : Pillar Clinical Research, LLC

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Dallas : UT Southwestern Medical Center

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Desoto : Insite Clinical Research

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Desoto : Insite Clinical Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Desoto : Insite Clinical Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Friendswood : Bay Area Clinical Services

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Friendswood : Bay Area Clinical Services

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Houston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Houston : Claghorn-Lesem Research Clinic

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Houston : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Houston : Forest Investigative Site 005 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Houston :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Houston : Ben Taub General Hospital

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Houston : Claghorn-Lesem Research Clinic, Ltd.

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Houston :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Houston :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Houston : Ben Taub General Hospital

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Houston : Red Oak Psychiatry Associates, Pa

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Houston : Ut Health-Houston

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Houston : Forest Investigative Site 070 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Houston : Call for Information (Investigational Site 0031)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)

Houston : Forest Investigative Site 011

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Houston : Forest Investigative Site 027

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Houston : Forest Investigative Site 016

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Houston : Alain Katic, MD

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Houston : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Houston : Bayou City Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Houston : Red Oak Psychiatry Associates, P.A.

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Irving : University Hills Clinical Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Lake Jackson : R D Clinical Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Lake Jackson : R/D Clinical Research

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Plano : Forest Investigative Site 010

Safety and Efficacy of Vilazodone in Major Depressive Disorder

San Antonio : Univ of Texas Helath Science Center at San Antonio

12- Week Open Label Treatment of Refractory Bipolar Depression

San Antonio : Clinical Trials of Texas

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

San Antonio : Clinical Trials of Texas, Inc.

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

San Antonio : Clinical Trials of Texas, Inc

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

San Antonio : Clinical Trials of Texas, Inc.

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

San Antonio : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

San Antonio : Clinical Trials of Texas, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Antonio : Forest Investigative Site 080 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

San Antonio : Call for Information (Investigational Site 0043)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)

San Antonio : Forest Investigative Site 002

Safety and Efficacy of Vilazodone in Major Depressive Disorder

San Antonio : Forest Investigative Site 016

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

San Antonio : Forest Investigative Site 020

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

San Antonio : Forest Investigative Site 034

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

The Woodlands :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Wharton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Wharton : Wharton Research Center, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Wichita Falls : Grayline Clinical Drug Trials

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Wichita Falls : Grayline Clinical Drug Trials

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Wichita Falls : Grayline Clinical Drug Trials

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Wichita Falls : Grayline Clinical Drug Trials

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Wichita Falls : Grayline Clinical Drug Trials

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Witchita Falls : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Murray : Radiant Research - Salt Lake City

Clinical Research Study for Depression

Murray : Radiant Research - Salt Lake City

Depression Research Study

Murray : Radiant Research - Salt Lake City

Research Study for Depressiondep

Salt Lake CIty : Lifetree Clinical Research

Depression

Salt Lake CIty : Lifetree Clinical Research

Depression

Salt Lake CIty : Lifetree Clinical Research

Depression

Salt Lake City : CRI Lifetree

This study is designed to evaluate the efficacy, safety, and tolerability of cariprazine relative to placebo for the treatment of major depressive disorder as an adjunct to ADT

Salt Lake City : CRI Lifetree

To compare the change from baseline (Week 7 in Phase B) to endpoint (Week 13 in Phase C) in MADRS score of 2 fixed-doses of BMS-820836 (1 and 2 mg/day) versus continuation of the antidepressant treatment to which inadequate response has been prospectively demonstrated in subjects with TRD.

Salt Lake City : CRI Lifetree

To evaluate the efficacy of 6 weeks treatment of RO4995819 versus placebo as adjunctive therapy in patients with MDD having inadequate response to ongoing antidepressant treatment based on mean change in Montgomery Asberg Depression Rating Scale (MADRS) scores from baseline to end of treatment.

Salt Lake City : CRI Lifetree

To evaluate the efficacy of 6 weeks treatment of RO4995819 versus placebo as adjunctive therapy in patients with MDD having inadequate response to ongoing antidepressant treatment based on mean change in Montgomery Asberg Depression Rating Scale (MADRS) scores from baseline to end of treatment.

Salt Lake City : CRI Lifetree

To evaluate the efficacy of treatment with flexible doses of Lu AA21004 (10 or 20 mg QD) versus placebo on cognitive dysfunction in patients with MDD

Salt Lake City : CRI Lifetree

To evaluate the mean difference in Hamilton Depression Rating Scale 17 (HDRS-17) score for the combined GLYX 13 group mean change versus the placebo group mean change at the end of a 6 week randomized withdrawal phase (predose baseline score - score at end of randomized withdrawal period).

View More »

Clinton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Clinton : Ericksen Research And Development

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Clinton : Ericksen Research and Development

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Clinton : Ericksen Research And Development

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Clinton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

Murray : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Murray : Radiant Research, Inc.

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Murray : Radiant Research, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Murray : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Orem : Aspen Clinical Research

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Orem : Forest Investigative Site 030 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Orem :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Orem : Aspen Clinical Research, LLC

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Salt Lake City : Fatigue Consultation Clinic

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Salt Lake City : Lifetree Clinical Research, LC

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Salt Lake City : Lifetree Clinical Research

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Salt Lake City :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Salt Lake City : University of Utah

Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram

Salt Lake City : Clinical Methods Llc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Salt Lake City :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Salt Lake City : Clinical Methods Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Salt Lake City : Psychiatric And Behavioral Solutions

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Salt Lake City : Forest Investigative Site 028 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Salt Lake City : Clinical Methods

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Woodstock : Neuropsychiatric Associates

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Woodstock : Neuropsychiatric Associates

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Woodstock : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Charlottesville : Charlottesville Medical Research

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Charlottesville : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Herndon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Herndon : Neuroscience, Inc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Herndon : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

View More »

Richmond : Alliance Research Group

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Richmond : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Richmond : Alliance Research Group

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Richmond : Virginia Commonwealth University

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Richmond : Virginia Treatment Center for Children

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Richmond : Virginia Commonwealth University

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Richmond : Alliance Research Group

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Richmond : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Richmond : Alliance Research Group

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Roanoke : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Roanoke :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Bellevue : Northwest Clinical Research Center

Depression

Bellevue : Northwest Clinical Research Center

Depression & Menopause

Seattle : Summit Research Network (Seattle) LLC

Depression Research Study

Seattle : Summit Research Network (Seattle) LLC

Depression Research Study

View More »

Bellevue : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Bellevue : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Bellevue : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Bellevue : Northwest Clinical Research Center

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Bellevue : Northwest Clinical Research Center

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Bellevue : Forest Investigative Site 032 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Bellevue : Forest Investigative Site 059

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Bellevue : Forest Investigative Site 006

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Bellevue : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Kirkland : Eastside Therapeutic Resource

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Kirkland : Eastside Therapeutic Resource

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Kirkland :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Kirkland : Forest Investigative Site 034 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Kirkland : Eastside Therapeutic Resource

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Richland : Scientella, LLC.

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Seattle : Summit Research Network (Seattle) LLC

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Seattle : Summit Research Network (Seattle) LLC

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Seattle : Forest Investigative Site 043 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Seattle :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Seattle :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Seattle : Summit Research Network (Seattle) LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Seattle :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Seattle : Summit Research Network (Seattle) Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Seattle : Forest Investigative Site 013

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Seattle : Forest Investigative Site 032

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Seattle : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Spokane : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Spokane : Forest Investigative Site 054

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Spokane : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Spokane : Frontier Institute

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Brown Deer :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Brown Deer : Northbrooke Research Center

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Brown Deer : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Brown Deer : Northbrooke Research Center

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Middleton : Dean Foundation for Health, Research & Education

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

View More »

Middleton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Middleton : Dean Foundation For Health Research & Education

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Middleton : Forest Investigative Site 052

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Middleton : Dean Foundation for Health, Research and Education, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Middleton : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Milwaukee : Rogers Center for Research and Training, Incorporated

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Milwaukee : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Milwaukee : Rogers Center for Research and Training, Incorporated

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Milwaukee :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Milwaukee : Forest Investigative Site 056

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Waukesha : Forest Investigative Site 057 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Waukesha :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Waukesha : Independent Psychiatric Consultants, Sc, Dba, Ipc Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Waukesha : Independent Psychiatric Consultants, SC, dba, IPC Research

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Buenos Aires : B.A. Psychiatric Research Cent

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Buenos Aires : INECO

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Buenos Aires : Dr. Gregorio Hugo Sorin

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Buenos Aires : Instituto FLENI

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Córdoba : Sanatorio Prof. León S. Morra SA

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

View More »

Rosario : Centro de Investigación y asistencia en Psiquiatria (CIAP)

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Adelaide : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Brisbane : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Brisbane : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Everton Park : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Frankston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

View More »

Heidelberg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Heidelberg : AU004

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Heidelberg : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Malvern : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Malvern : Neurotherapy Victoria Clinical Trials

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Melbourne : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Melbourne : The Alfred Hospital

International Study to Predict Optimised Treatment - in Depression

Melbourne : Swinburne University

International Study to Predict Optimised Treatment - in Depression

Melbourne : Monash Alfred Psychiatry Research Centre

Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression

Melbourne : Northern Area Mental Health Services Northern Psychiatric R

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Nedlands : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Nedlands : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Spring Hill : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Sydney : The University of New South Wales/ Black Dog Institute

A Study of Omega-3 as a Treatment for Major Depression

Sydney : The University of New South Wales/Black Dog Institute

A Study of Omega-3 as an Augmentor of Antidepressant Treatment for Major Depression

Westmead : Brain Dynamic Centre

International Study to Predict Optimised Treatment - in Depression

Innsbruck :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Neunkirchen : AT004

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Vienna : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Vienna : AT003

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Wien : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

View More »

Wien : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Wien, Vienna :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Brugge : BE001

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Dave : Updated

A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

Diest : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Duffel :

Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder Patients

Heusden-Zolder : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

View More »

Kortenberg : Updated

A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

Lede : Updated

A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

Leuven :

Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder Patients

Liège : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Mont-Godinne : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Sint-Niklaas : BE003

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Bourgas : Updated

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Bourgas : BG001

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Bourgas : District Department of Psychiatric Disorders With Stationary

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Pazardjik : State Psychiatric Hospital - Pazardjik

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Pazardzhik : BG002

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

View More »

Pleven : Forest Investigative Site 302

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Pleven : Psychiatric clinic for women UMHAT "Dr. Georgi Stranski"

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Plovdiv : Forest Investigative Site 301

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Plovdiv : ODPZS- EOOD, Plovdiv, Bulgaria

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Rousse : Updated

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Sofia : BG003

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Sofia : BG005

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Sofia : Forest Investigative Site 306

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Sofia : Psychiatric clinic, University Hospital "Alexandrovska"

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Sofia : MHAT Doverie

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Varna : Updated

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Varna : BG004

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Varna : Diagnostic Consultative Center "Tchaika"

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Varna : MHAT - Sveta Marina

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Kelowna, BC : Okanagan Clinical Trials

Are you being treated for depression and experiencing sexual dysfunction as a result of your antidepressant medication?

View More »

Brampton : Dr. Naresh Aggarwal

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Burlington :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Chatham : Chatham-Kent Clinical Trials Research Center

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Chatham : CA008

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Chatham : Forest Investigative Site 101

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Edmonton : Grey Nuns Hospital

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Gatineau :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Gatineau : Richard Bergeron, M.D.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Gatineau : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Hamilton : Women's Health Concerns Clinic

Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and Women

Hamilton : Women's Health Concerns Clinic

Duloxetine for Major Depression in Peri-/Postmenopausal Women

Hamilton : St. Joseph's Healthcare, Centre for Mountain Health Services

Longitudinal Study of People Presenting for First Treatment of a Mood Disorder

Hamilton : McMaster University Medical Centre

Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders

Kelowna : Forest Investigative Site 102

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Kentville :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Kingston :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Kingston : Providence Care Mental Health Services

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Kirkland : Merck Frosst Canada Ltd.

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)

London : Regional Mental Health Care

Aripiprazole and Resistant Postpartum Depression

Medicine Hat :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Medicine Hat : Forest Investigative Site 104

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Mississauga :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Mississauga : Anxiety and Mood Disorder Center

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Mississauga : Medical Research Associates

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Montreal : Centre de Recherche Fernand-Seguin

Effect of Antidepressants on White Matter Structure

Montreal : CA001

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Montreal : Centre de Recherche Fernand Seguin

Inflammatory Markers and Cognitive Function in Major Depression

Montreal : Hôpital Louis Hlafontaine

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Montreal : Immunodeficiency Service Montreal Chest Institute McGill University Health Centre

Trial of Citalopram for the Prevention of Depression

Montréal : Douglas Mental Health University Institute

Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study

Oakville : Satpal Girgla M.D.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Oakville : CA007

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Ottowa :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Parry Sound : International Sleep Clinic, West Parry Sound Health Centre

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Penticton : Dr. Alexander McIntyre Inc.

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Penticton :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Penticton : Alexander McIntyre, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Penticton : Forest Investigative Site 103

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Penticton : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Penticton : Dr. Alexander McIntyre, Inc.

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Pointe-Claire : Kells Medical Research Group Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Quebec : ALPHA Recherche Clinique

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Sherbrooke : Diex Research Sherbrooke Inc.

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Sherbrooke :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Sherbrooke : Q&T Research Sherbrooke

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Sydney :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Thornhill : Canadian Centre for Clinical Trials

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Toronto : University Health Network - Toronto General Division

A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder

Toronto : University Health Network - Toronto Western Division

A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder

Toronto :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Toronto : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Toronto : Manna Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Toronto : Martin Katzman, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Toronto : Sleep & Alertness Clinic (Sleep & Alertness Research, Inc.)

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Toronto : CA002

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Toronto : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Vancouver : Dr. D. McIntosh & Dr. K. Kjernisted Clinical Research Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Vancouver : CA006

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Vancouver : University of British Columbia, Department of Psychiatry

Neurocognition and Work Productivity in Major Depressive Disorder (MDD)

Vancouver : Institute of Mental Health, University of British Columbia

What is the Antidepressant Mechanism of Action of Quetiapine in Bipolar Depression?

Antofagasta : Luis Alberto Barra Ahumada, MD

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Las Condes : Dr. Claudia Carolina Barrera Renault

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Las Condes : Guillermo Antonio Vergara Harris, MD

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Providencia : Sergio Moises Gloger Kojchen

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Miguel : Dr. Marcela Eugenia Rojas Segura

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

View More »

Santiago :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Santiago : Jaime Marvele Solis Gonzalez

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Santiago : Manuel Jesus Sebastian Lavados Montes

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Baoding : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

Beijing : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

Beijing : CN001

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Changsha : The Second Xiangya Hospital of Central South University

A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression

Guang Zhou : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

View More »

Hangzhou : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

Harbin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

Kunming : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

Nanjing : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

Shanghai : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

Xi'An : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

Rab : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Rijeka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Split : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Zagreb : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Zagreb : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

View More »

Zagreb : Psychiatric Hospital Vrapce

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Brno : CZ012

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Brno : CZ003

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Brno : Jan Holan, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Brno : Michaela Klabusayova, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Horovice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

View More »

Horovice : Oto Markovic, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Hostivice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Kladno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Kutna Hora : Psychiatrie s.r.o.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Litomerice : Bialbi s.r.o.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Olomouc : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Olomouc : CZ005

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Prague : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Prague 10 : Clintrial s.r.o.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Prague 5 : Psychiatry Trial s.r.o.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Prague 6 : Prague Medical Services s.r.o.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Praha : CZ004

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Praha : CZ006

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Praha 1 : CZ009

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Praha 10 : CZ008

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Praha 6 : CZ002

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Praha 9 : CZ010

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Ricany : Jan Cernak, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Strakonice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Usti Nad Labem : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Roskilde : The day clinic for treatment of non-psychotic disorders (Roskilde Psychiatry)

Mindfulness-based Behavioural Therapy (MIBT) Versus Psychodynamic Therapy for Patients With Major Depressive Disorder in Psychotherapeutic Day Treatment. A Randomised Clinical Pilot Trial

Parnu : EE003

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Tallinn : EE001

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Tallinn : EE005

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Tallinn : Forest Investigative Site 203 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Tallinn : Forest Investigative Site 206 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

View More »

Tallinn : Forest Investigative Site 201 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Tallinn : Forest Investigative Site 205 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Tartu : EE002

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Tartu : EE004

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Tartu : Forest Investigative Site 207 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Tartu : Forest Investigative Site 204 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Tartu : Forest Investigative Site 208 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Võru : Forest Investigative Site 202 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Helsinki : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Helsinki : FI004

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Helsinki : FI002

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Helsinki : FI008

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Helsinki : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

View More »

Helsinki : Forest Investigative Site 304 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Helsinki : Forest Investigative Site 301 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Helsinki : Forest Investigative Site 302 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Helsinki : Forest Investigative Site 306 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Helsinki : FF Servies OY/ FF Reseach

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Helsinki : Helsingin kaupunki, Auroran sairaala

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Jarvenpaa : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Joensuu : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Jyväskylä : Forest Investigative Site 303 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Kangasala : Kaivannon sairaala

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Kuopio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Kuopio : FI001

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Kuopio : Forest Investigative Site 305 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Lohja : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Oulu : FI009

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Oulu : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Oulu : Forest Investigative Site 308 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Pori : Forest Investigative Site 307 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Rauma : FI006

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Seinajoki : FI003

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Tampere : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Tampere : FI005

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Tampere : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Turku : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Turku : Turun psykiatripalvelu

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Arcachon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Arcachon : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Besancon : CHU Besancon - Clinical Psychaitric Department

Study of Transcranial Direct Current Stimulation (tDCS) as add-on Treatment for Resistant Major Depression

Besançon : C.H.U. Saint-Jacques - Service de Psychiatrie de l'Adulte

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Bron : C.H. Le Vinatier - EA 4166, UCB Lyon 1 - Department of Psychiatry - Service du Pr d'AMATO

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

View More »

Caen : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Caen : FR003

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Clermont Ferrand : C.H.U. Gabriel Montpied - Service de Psychiatrie et Psychologie Médicale - CMP A

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Colombes : Hôpital Louis Mourier

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Dijon : C.H.U. Dijon, Hôpital Général - Service de Psychiatrie et d'Addictologie

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Dijon Cedex : FR008

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Dole : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Dole : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Dole : CMP/CHS du Jura

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Douai : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Douai : FR006

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Douai : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Elancourt : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Elancourt : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Elancourt : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Fains : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Grenoble : C.H.U. de Grenoble, Hôpital sud - Département de Psychiatrie

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Jonzac : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Jonzac : Centre Hospitalier de Jonzac

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Lézignan-Corbières : ASM Limoux

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Lille : Hôpital Fontan - C.H.R.U. Lille

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Limoges Cedex : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Marseille : C.H. Sainte Marguerite

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Montpellier : CHU - Hôpital La Colombière

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Montpellier Cedex 5 : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Nice : CHU Pasteur

European Deep Brain Stimulation (DBS) Depression Study

Nice : Hôpital Pasteur - CHU Nice

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Nîmes : Hopital Universitaire Caremeau-Batiment Polyvalent, Service

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Orvault : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Palaiseau : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Paris : FR

A Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder

Paris : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Paris : Hôpital Sainte Anne - Service Hospitalo-Universitaire de Santé Mentale et de Thérapeutique

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Poitiers : C.H.U. de POITIERS

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Rennes : C.H.U. - C.H. Guillaume Régnier

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Rouen : C.H.U. Charles Nicolle - Service Hospitalo-Universitaire de Psychiatrie

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Saint-Denis : EPS de Ville Evrard - Unité de Saint-Denis

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

St Etienne cedex : CHU St Etienne - Hôpital Nord

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Toulon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Toulouse : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Toulouse : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Tours : CPU CHRU de Tours

BDNF Gene Polymorphism and Antidepressants Treatment

Achim : Andreas Mahler, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Achim : DE007

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Achim : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Achim : Praxis Dr. Andreas Mahler

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Bad Saarow : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

View More »

Baesweiler : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Berlin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Berlin : DE005

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Berlin : Updated

A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

Berlin : Jana Thomsen, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Berlin : Alexander Schulze, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Berlin : emovis GmbH

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Berlin : DE005

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Berlin :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Berlin : Charité - Universitätsmedizin Berlin

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Bochum : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Bochum : Ralf Bitter, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Bonn : University Clinic Bonn

The Effect of Duloxetine on Interoceptive Awareness

Butzbach : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Cham : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Cologne : University of Cologne

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Dortmund : Research Site

European Drug Utilization Study

Dresden : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Dresden : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Dresden : Universitatsklinikum Carl Gustav Carus

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Düsseldorf : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Erfurt : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Essen : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Freiburg : Updated

A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

Freiburg :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Freiburg : University of Freiburg

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Gelsenkirchen : DE004

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Göttingen : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Hamburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Hannover : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Hattingen : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Heidelberg : DE003

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Ingolstadt : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Kandel : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Leipzig : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Leipzig : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Leipzig : DE001

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Leipzig : Marion Schnabel, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Ludwigshafen : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Mainz : Updated

A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

Mainz :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Mannheim :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Marburg : Department of Clinical Psychology and Psychotherapy, Philipps University Marburg

End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)

Mittweida : Pharmakologisches Studienzentrum Chemnitz GmbH, Außenstelle

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Muenchen : Studienzentrum Muenchen

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Munich : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Munich : Department of Psychiatry and Clin. Radiology, Ludwig-Maximilian-University

Somatosensory Processing in Depression

Nuernbeg : Isabel Hach, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Nurnberg : DE009

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Nürnberg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Nürnberg :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Oranienburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Ostfildern :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Prien : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Schönau am Königssee : Klinikum Berchtesgadener Land, Schön Kliniken

End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)

Schwerin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Schwerin : Somni bene GmbH

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Schwerin, Mecklenburg-vorpomme :

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Stralsund : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Wermsdorf : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Westerstede : Studiezentrum Nord-West

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Wuerzburg : Medizinisches Studienzentrum Wuerzburg

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Wurzburg : DE001

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Wurzburg : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Haidari : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Thessaloniki : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Tripoli : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Baja : Updated

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Baja N/A : Updated

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Budapest : Updated

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Budapest : Istvan Bitter

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Budapest : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

View More »

Budapest : Semmelweis University, Psychiatric Clinic

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Budapest : Obudai Egeszsegugyi Centurm Kft.

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Budapest : Forras Outpatient Clinic

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Budapest : Varoskapu Outpatient Clinic

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Gyor : Petz Aladar Megyei Oktatokorhaz Pszichiatriai Osztaly

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Kalocsa : Updated

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Nagyerkei : Ede Frecska, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Nagykalio : Csilia Varga, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Nagykallo : Santha Kalman Szakkkorhaz

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Nyfregyhaza : Alexander Kancsev, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Ahmedabad : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Varanasi : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Hod Hasharon : shalvataMHC

Double Blind Randomized Controlled, H1 Coil In Subjects With Bipolar Depression

Jerusalem : Hadassah-Hebrew University Medical Center

European Deep Brain Stimulation (DBS) Depression Study

Tel Hashomer : Sheba Medical Center, Department of psychiatry

Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder

Camaiore-Viareggio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Catania : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Catania : Azienda Ospedaliero Univ. Policlinico - Vittorio Emanuele

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Colleferro : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Ferrara : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

View More »

Firenze : S.O.D. of Psychiatry, A.O.U. Careggi

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Genova : Clinica Psichiatrica (Pad. A), A.O. Ospedale San Martino

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Milan : IT001

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Pisa : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Pisa : Centro per i disturbi del sonno

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Roma : Ospedale Sant'Andrea,Servizio Psichiatrico di Diagnosi e Cur

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Siena : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Turin : IT002

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Adachi-ku : Suzuki Hospital

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Adachi-ku : Suzuki Hospital

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Amagasaki : Arai Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Amagasaki-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Anan-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

View More »

Annaka-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Ashiya : Terauchi-Takahashi Psychiatric Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Ashiya : Terauchi-Takahashi Psychiatric Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Chiba : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Chiba : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY221668412 in Patients With Major Depression Disorder

Chiyoda-ku : Iidabashi Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Chubu :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Chugoku :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Chuo-ku :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Fujioka-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Fujisawa-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Fukaya-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Fukuoka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Fukuoka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Fukuoka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY221668412 in Patients With Major Depression Disorder

Fukuoka : Stress Care Yoshimura Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Fukuoka : Tenjin Mental Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Fukuoka : Kuranari Psychiatry Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Fukuoka : Imato Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka : Medical Corporation Shinseikai Kaku Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka : Tenjin Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka : Stress Care Yoshimura Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka : Sugahara Tenjin Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka : Akasaka Kato Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka : Ange Psychiatric Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka : Hiro Mental Clinic Tenjinminami

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka : Kuranari Psychiatry Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka-city :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Fukuoka-city : Hatsuki Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka-shi : Stress Care Yoshimura Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Fukushima : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Fukushima : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Hachioji-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Hatsukaichi : Fujikawa Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Hatsukaichi : Fujikawa Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Hatsukaichi-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Hirakata : Kuginuki Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Hiroshima : Tsuji Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Hiroshima-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Hokkaido : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Hokkaido : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY221668412 in Patients With Major Depression Disorder

Hokkaido :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Hokkaido :

Long-term Study of FK949E in Elderly Bipolar Disorder Patients

Hokkaido :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Hokkaidou :

Study to Evaluate the Effect and Safety of FK949E in Major Depressive Disorder Patients

Hyogo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Hyogo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Hyogo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY221668412 in Patients With Major Depression Disorder

Ibaraki :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Inzai : Nippon Medical School Chiba Hokusoh Hospital

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Inzai : Nippon Medical School Chiba Hokusoh Hospital

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Inzai-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Kanagawa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Kanagawa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Kanagawa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY221668412 in Patients With Major Depression Disorder

Kanagawa :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Kanagawa : Medical Corporation Toyokokai Tawara Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Kanazawa : National Hospital Organization Kanazawa Medical Center

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Kanazawa : National Hospital Organization Kanazawa Medical Center

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Kansai :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Kanto :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Kantou :

Study to Evaluate the Effect and Safety of FK949E in Major Depressive Disorder Patients

Katsushika-ku :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Katsushika-ku : Fuku Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Kawasaki : Kishiro Mental Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Kawasaki : Kishiro Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Kawasaki-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Kinki :

Study to Evaluate the Effect and Safety of FK949E in Major Depressive Disorder Patients

Kita-ku :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Kitakyushu-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Kobe : Ikeuchi Psycho Induced Internal Med.Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Kobe : Ikeuchi Psycho Induced Internal Med.Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Kobe : Tatsuta Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Kobe-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Kumamoto-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Kumamoto-shi : Yuge Hospital

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Kurashiki-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Kurayoshi-shi :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Kure : Hayakawa Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Kyoto : Sagaarashiyama-Tanaka Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Kyoto : Sagaarashiyama-Tanaka Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Kyoto-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Kyushu :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Minato-ku : Akasaka Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Minato-ku : SAKURAZAKA CLINIC SophyAnce

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Musashino-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Nagano : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Nagano : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Nagano : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY221668412 in Patients With Major Depression Disorder

Nagareyama : Hida Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Nagoya : Mizuho Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Nagoya : Narumi Himawari Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Nakano-Ku : Harikae mental clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Nakano-ku : Heartcare Ginga Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Nanyo-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Nara : Kyo Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Noda City : Nakamoto Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Noda City : Nakamoto Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Noda-City :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Omuta : Shiranui Hospital

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Omuta : Shiranui Hospital

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Omuta-city : Oka Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Osakasayama-shi : Shibamoto Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Osaka-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Osaka-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Saga : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Saga : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY221668412 in Patients With Major Depression Disorder

Sagamihara : Yutaka Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Sagamihara : Yutaka Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Sagamihara-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Saitama : Misato Ekimae Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Saitama-city :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Saitama-city : Sakai Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Sapporo-Shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Sapporo-Shi : Kawamura Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Setagaya-ku : Sangenjaya Nakamura Mental Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Setagaya-ku : Sangenjaya Nakamura Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Setagaya-ku : Komazawa Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Shibuyaku : Yoyoginomori Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Shibuya-ku : Maynds Tower Mental Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Shibuya-ku : Omotesando Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Shibuya-ku : Maynds Tower Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Shikoku :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Shinagawa-Ku : Himeno Tomomi Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Shinagawa-ku : Meguro sta.East Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Shinjuku-ku :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Shinjuku-ku : Tokyo Kosei Nenkin Hospital

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Shinjuku-ku : Nishi-Shinjuku Concieria Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Shinjuku-ku : Tokyo Kosei Nenkin Hospital

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Shinjuku-ku : Kagurazaka Stress Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Shinjuku-ku : Tamaki Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Taito-Ku : Local Institution

Japanese Phase 1 Multiple Ascending Dose (MAD) Study

Takasaki-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Tokushisma-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Tokyo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Tokyo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Tokyo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY221668412 in Patients With Major Depression Disorder

Tokyo :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Tokyo :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Tokyo : Omotesando Mental Clinic 9F Success Aoyama

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Tokyo : Eto Mental Clinic Meguro

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Toshima-ku : Himorogi Psychiatric Institute

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Toshima-ku : Himorogi Psychiatric Institute

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Touhoku :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Utsunomiya-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Yokohama : Tawara Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Yokohama : Medical Coporation Toyokokai Tawara Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Yokohama-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Yokohama-Shi : Azamino Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Yokosuka city : Shioiri Mental Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Yokosuka city : Shioiri Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Ansan : 03

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Ansan : Korea University Ansan Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Anyang : 19

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Anyang : Hallym Univesity Sacred Heart Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Bucheon : KR005

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

View More »

Busan : 26

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Busan : 08

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Busan : Dong-A University Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Chungbuk : 23

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Daegu : 04

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Daegu : 05

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Daegu : Dongsan Medical Center

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Daejeon : Chungnam National University Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Daejon : 16

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Goyang : 28

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Goyang : Dongguk University International Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Guri : Hanyang University Guri Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Gwangju : Chonnam National University Hospital

Escitalopram in Depressive Patients With Acute Coronary Artery Syndrome

Gwangju : 29

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Gwangju : 24

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Gwangju : Chosun University Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Gyeonggi-Do : 11

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Gyeonggi-do : Kwandong University College of Medicine Myongji Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Inchon : Inha University Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Jinju : 15

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Kangnam : Samsung Medical Center

Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning

Seoul : Seoul National University Hospital

Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder

Seoul : Seoul National University Hospital

Lexapro®'s Efficacy After Dose Escalation in Remission Study

Seoul : Seoul National University Hospital

Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients

Seoul : Seoul St. Mary's Hospital

Quality of Life and Depression in Dialysis Patients

Seoul : 13

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 14

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 18

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 20

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 21

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 06

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 07

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 09

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 27

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 01

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 02

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 17

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 22

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 10

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 12

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : KR001

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Seoul : KR006

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Seoul : KR007

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Seoul : KR002

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Seoul : KR003

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Seoul : Konkuk Univ. Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Seoul : Asan Medical Center

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Seoul : KyungHee University Medical Center

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Seoul : Severance Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Sungnam : KR004

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Yangsan : 25

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Daugavpils : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Daugavpils : LV006

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Jelgava : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Jelgava : LV002

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Liepaja : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

View More »

Liepaja : LV004

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Riga : LV003

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Sigulda : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Sigulda : LV005

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Strenci : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Strenci : LV001

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Kaunas : LT001

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Kaunas : LT003

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Klaipeda : LT004

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Palanga : LT006

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Vilnius : LT005

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

View More »

Vilnius : LT002

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Aguascalientes :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Leon Gto : MX001

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Leon Guanajuato : Juan Luis Vazquez-Hernandez

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

León, Guanajuato :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Mazatlan : MX003

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

View More »

Monterrey : MX005

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Monterrey :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Nuevo Leon : Jose Alfonso Ontiveros, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Nuevo Leon : Omar Kawas Valle

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Sinaloa : Gabriel Bernal Gamboa

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Monaco : Centre Hospitalier Princesse Grace

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Nijmegen : Brainclinics Diagnostics B.V.

International Study to Predict Optimised Treatment - in Depression

Auckland : University of Auckland

International Study to Predict Optimised Treatment - in Depression

Lorenskog : Akershus University Hospital

Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin Therapy

Manila : Private Clinic

Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients

?Uromin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Bialystok : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Bialystok : Prywatne Gabinety Lekarskie "Promedicus"

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Bialystok :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Bydgoszcz : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

View More »

Bydgoszcz : Professor Aleksander Araszkiewicz

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Bydgoszcz : Szpital Uniwersytecki im.dr.A.Jurasza w Bydgoszczy

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Chelmno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Chelmno : Zespol Opieki Zdrowotnej w Chelmnie

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Choroszcz :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Gdansk : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Gdansk : PL001

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Gdansk : Updated

A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

Gdansk : Wojewodzki Szpital Psychiatryczny im. prof. Tadeusza Bilikie

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Gdansk : Klinika Chorob Psychicznych i Zaburzen Nerwicowych GUM

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Gdynia : PL002

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Gdynia :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Gdynia : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Gorlice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Gorlice : PL008

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Gorlice : Centrum Psychiatrii i Psychoterapli

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Katowice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Katowice : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Kielce : NZOZ Syntonia, Poradnia Zdrowia Psychicznego

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Krakow : Malopolskie Centrum Medyczne

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Leszno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Lodz :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Lublin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Lublin : PL006

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Lublin : PL007

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Lublin : Osrodek Badafi Klinicznych Prof dr hab n med Meszek Szczepanski Prywatna Praktyka Lekarska

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Lublin : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Skorzewo : PL003

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Torun : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Torun : PL005

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Torun :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Tuszyn : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Tuszyn : PL010

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Tuszyn :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Tuszyn : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Warszawa : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Zuromin : Samodzielny Publiczny Zespol Zakladow Opieki Zdrowotnej w Zurominie

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Corozal : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Ponce : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Ponce : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Ponce : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Juan : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

View More »

San Juan : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

San Juan : Forest Investigative Site 033 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

San Juan : Forest Investigative Site 034 Updated

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

San Juan : INSPIRA Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Juan : Dharma Institute & Research Center

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Arad : Updated

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Arad : RO005

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Arad : Spitatul Clinic Judetean de Urgenta Arad, Clinica de Psihiatrie

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Botosani : Stefi-Dent SRL

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Bucaresti : Spitalui Clinic de Psihiatrie "Prof. Dr. Alexandru Obregia" Sectia Clinica Psihiatrie I

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

View More »

Bucharest : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Bucharest : RO002

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Bucharest : RO003

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Bucharest : RO004

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Bucuresti :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Constanta :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Craiova : RO001

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Craiova :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Focsani : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Focsani : RO007

A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication

Iasi : Updated

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Oradea : Crucea Alba

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Targouiste :

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Targoviste : Lorentina 2201 SRL

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Targu Mures : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Targu Mures : Spitalul Clinic Judetean Mures

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder